STK-001-DS-501 - An Open-Label Extension Study for Patients with Dravet Syndrome who Previously Participated in Studies of STK 001

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Dravet Syndrome
  • Age: Between 2 Year(s) - 18 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Participants must be =2.5 years of age
    2. Participants and/or their legal guardians must be willing and able to give informed consent/assent and any authorizations required by local law for participation in the study
    3. Partici

You may not be eligible for this study if the following are true:

    1. Participants have met any withdrawal criteria from Study STK-001-DS-101
    2. Currently being treated as maintenance therapy with an antiepileptic drug acting primarily as a sodium channel blocker including phenytoin, carbamazepine, oxcarb

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.